Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Background and aims: HRS9531, a novel once-weekly dual GLP-1/GIP receptor agonist, has demonstrated preliminary efficacy in glycemic control and weight loss, with good tolerability in patients with T2DM in a phase 1 trial
Form of Peptide: lyophilized, no stabilizers or preservatives
GLP-1 receptor activation in hypothalamic and brainstem appetite centers directly suppresses hunger and enhances satiety signaling
The study also couldnt account for factors like how well patients actually took their medications, lifestyle changes, or genetic predisposition to dementia
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
